Managed Care Pharmacy Implications from CMS Potential Drug Pricing and Medicare Part D Proposed Rules
Webinar Recorded on November 9, 2018
Join AMCP for a first look at the major provisions contained in a recently released advanced notice of proposed rulemaking from CMS on the International Drug Pricing Index for Part B drugs and a recently proposed rule on the Medicare Advantage and Part D Program. This webinar will summarize and analyze the provisions of both the advanced notice of proposed rulemaking and proposed rule that are of greatest impact to managed care pharmacy. Be one of the first to know and help inform AMCP’s comments to CMS!
- Melissa Andel, MPP
Vice President, Health Policy
Applied Policy, LLC
- Stephen Northrup, MPA
Rampy Northrup LLC and AMCP Legislative Consultant